Search Results 831-840 of 17432 for Mmol
This phase I trial studies the side effects and best dose of paclitaxel albumin-stabilized nanoparticle formulation and bevacizumab in treating patients with ...
About this study. The purpose of this study is to develop and test a wide range of software, all designed to operate an MRI scanner more efficiently - to ...
The purpose of this study is to prospectively validate urine cytokines (e.g. TNF-α and CXCL9) and urinary T cells as non-invasive biomarkers to distinguish ...
Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Learn more about the Molecular Pharmacology and Experimental Therapeutics Program (MPET) at Mayo Clinic Graduate School of Biomedical Science.
The Markovic Melanoma Research Lab at Mayo Clinic investigates immune homeostasis, platform nanomedicines, and novel vaccine strategies and adjuvants for ...
This is a multi-center, open label, single arm phase II study evaluating BGJ398 anti-tumor activity in advanced or metastatic cholangiocarcinoma patients with ...
About this study. The purpose of this study is to create an appropriate subject population for the clinical utility evaluations of the One Lambda Exosomes ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Ibrutinib may stop the growth of tumor cells by ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.